DCMM
AZN icon

DG Capital Management (Massachusetts)’s AstraZeneca AZN Stock Holding History

DG Capital Management (Massachusetts)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,118
Closed -$755K – 62
2015
Q4 		$755K Buy
+11,118
New +$729K 0.67% 52
2015
Q2 		– Sell
-27,120
Closed -$1.86M – 66
2015
Q1 		$1.86M Buy
+27,120
New +$1.88M 1.12% 48

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

DG Capital Management (Massachusetts)'s AZN Position: Q1 2016 in Review

DG Capital Management (Massachusetts) sold out of AstraZeneca (AZN) in Q1 2016, closing a stake of 11,118 shares — an estimated $755K sold.

DG Capital Management (Massachusetts) first reported a position in AZN in Q1 2015 and held it in 2 quarters. The position peaked at $1.86M in Q1 2015. 390 funds tracked by Wall St. Rank hold AZN as of Q1 2016.

  • DG Capital Management (Massachusetts) reported no remaining AstraZeneca position as of Q1 2016 after selling out during the quarter.
  • DG Capital Management (Massachusetts) sold 11,118 AstraZeneca shares in Q1 2016, an estimated $755K.
  • DG Capital Management (Massachusetts) first reported a position in AstraZeneca in Q1 2015 and held it in 2 quarters.
  • DG Capital Management (Massachusetts)'s AstraZeneca position peaked at $1.86M in Q1 2015.
  • 390 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2016.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q1 2016, filed 11 May 2016.